What Raises Hemoglobin Levels: Diet, Supplements & Causes

Learn what naturally raises hemoglobin levels, from iron-rich foods and B12 to altitude, supplements, and when medical treatment is needed.

Hemoglobin levels rise when the body gets the raw materials it needs to build red blood cells, when hormonal signals ramp up red blood cell production, or when plasma volume shrinks and concentrates the red cells already circulating. For most people wondering how to raise a low reading, the answer starts with iron, because iron sits at the center of every hemoglobin molecule and is the nutrient most often lacking. But iron is only part of the picture. Folate, vitamin B12, vitamin A, vitamin C, and even copper all play roles, and the body’s own oxygen-sensing system can drive hemoglobin up or down depending on everything from altitude to kidney function to sleep quality.

How the Body Decides to Make More Hemoglobin

Your kidneys act as the body’s oxygen thermostat. When tissues detect that oxygen delivery is falling short, a signaling cascade triggers the kidneys to release erythropoietin (EPO), a hormone that travels to the bone marrow and tells it to produce more red blood cells. Each of those cells gets packed with hemoglobin, the protein that actually carries oxygen. This oxygen-sensing mechanism is the master switch behind nearly every route to higher hemoglobin, whether you are eating more iron, moving to a mountain town, or dealing with a lung condition that limits oxygen exchange.

The lungs and kidneys work together in this process. The lungs handle gas exchange while the kidneys calibrate EPO output based on how much oxygen the blood is actually delivering. Additional players include hypoxia-inducible factors (HIFs), inflammatory signals, and iron availability, all of which fine-tune how much EPO gets produced and how effectively the bone marrow responds to it.

Iron From Food and Why the Type Matters

Iron is the single most important dietary factor for hemoglobin production. Your body uses iron to build the heme group, the oxygen-binding core of hemoglobin. But not all dietary iron is created equal. Heme iron, found in meat, poultry, and fish, is absorbed through a different pathway than non-heme iron, which comes from plant foods, fortified cereals, and eggs. Heme iron is generally absorbed more efficiently and is less affected by other things you eat at the same meal.

Non-heme iron absorption, by contrast, is heavily influenced by what else is on your plate. Vitamin C is the most powerful dietary enhancer of non-heme iron uptake. It works by converting iron into a form your intestinal cells can actually absorb, and the effect is dose-dependent: more vitamin C at the meal means more iron gets through. Vitamin C can even partially counteract some of the compounds that block iron absorption.

On the other side of the equation, several common dietary components actively block non-heme iron absorption. The most significant inhibitors are phytic acid (found in whole grains, legumes, and nuts), polyphenols and tannins (in tea, coffee, and some fruits), soy protein, dairy calcium, and egg proteins. Polyphenol-rich fruits and vegetables can also reduce non-heme iron uptake, which is worth keeping in mind if you are trying to correct a deficiency. This does not mean you should avoid these foods entirely, but separating iron-rich meals from heavy tea drinking or large calcium supplements by an hour or two can make a real difference.

Vitamins and Minerals That Support Red Blood Cell Production

Iron gets the headline, but building healthy red blood cells is a group project. Folate and vitamin B12 are essential for the rapid cell division that happens when red blood cell precursors multiply in the bone marrow. When either is lacking, those precursor cells cannot replicate their DNA properly, and many of them die before maturing, leading to anemia even when iron stores are fine. This is why a blood test showing large, misshapen red blood cells often points toward a B12 or folate problem rather than an iron one.

Vitamin A plays a less obvious but genuinely important role. In animal studies, vitamin A deficiency reduced the kidney’s production of EPO, the hormone that drives red blood cell output. Without enough vitamin A, red blood cells formed abnormally and were destroyed prematurely in the spleen, creating a cycle of wasted iron and ineffective blood production. In populations where vitamin A deficiency is common, supplementation has been shown to improve anemia alongside iron.

Copper is another underappreciated contributor. It helps move iron out of intestinal cells and liver stores into the bloodstream by supporting enzymes called ferroxidases, including ceruloplasmin. Copper also appears to influence the activity of hepcidin, the hormone that controls how much iron your body absorbs and releases from storage. Severe copper deficiency can cause anemia that looks like iron deficiency but does not respond to iron supplements, a situation that occasionally trips up clinicians.

The Hepcidin Bottleneck

You can eat plenty of iron and still not absorb enough if your body’s internal gatekeeper is blocking the door. That gatekeeper is hepcidin, a hormone made by the liver. Hepcidin controls the only known iron exporter on the surface of intestinal and immune cells. When hepcidin levels are high, that exporter gets pulled inside cells and broken down, and iron stays trapped rather than entering the bloodstream.

Chronic inflammation is one of the biggest drivers of elevated hepcidin. Infections, autoimmune diseases, and chronic conditions like kidney disease or inflammatory bowel disease can all push hepcidin up, essentially locking iron away even when the body desperately needs it for hemoglobin. This is the mechanism behind “anemia of chronic disease,” a frustrating form of anemia where iron supplements alone often do not work because the iron never makes it from the gut into the blood.

Iron Supplements and How They Compare

When diet alone is not enough, iron supplements are the first-line treatment for iron-deficiency anemia. Ferrous sulfate is the most widely prescribed and studied form. Other oral options include ferrous gluconate, ferrous fumarate, and iron bisglycinate chelate, which is marketed as gentler on the stomach. In a trial of Mexican schoolchildren, bisglycinate chelate did produce higher ferritin stores at six months compared to ferrous sulfate, but hemoglobin concentration did not change significantly in either group after supplementation. A trial in Cambodian women found that a lower dose of bisglycinate was actually less effective than a higher dose of ferrous sulfate at raising ferritin, and neither showed meaningful differences in gut side effects. The takeaway: “gentler” formulations are not automatically better at raising hemoglobin, and the dose still matters.

For people who cannot tolerate oral iron or whose condition blocks absorption (as with the hepcidin problem described above), intravenous iron bypasses the gut entirely. A meta-analysis across multiple conditions found that IV iron raised hemoglobin more effectively than oral iron in people with chronic kidney disease, inflammatory bowel disease, cancer-related anemia, and general iron-deficiency anemia. IV iron also corrected hemoglobin faster and caused fewer gastrointestinal side effects. In postpartum women, a single low-dose IV infusion raised hemoglobin more at two weeks and produced dramatically higher ferritin at four weeks compared to oral ferrous sulfate. Similar advantages were seen in women with heavy menstrual bleeding. The trade-off is cost and the need for a clinical setting.

Altitude and the Oxygen-Sensing Response

Moving to a higher elevation is one of the most reliable ways to push hemoglobin up without any supplement. The lower oxygen pressure at altitude triggers the same EPO-driven pathway that any form of hypoxia activates, and the body responds in two phases. In the first days, plasma volume drops, concentrating the red cells already in circulation and producing a quick bump in hemoglobin concentration. Over weeks, the bone marrow ramps up production and total red cell volume genuinely expands.

This is why endurance athletes sometimes train at altitude or use altitude tents. Interestingly, research in cyclists training at different elevations found that while EPO rose and plasma volume expanded, the change in total hemoglobin mass was only trivially correlated with the EPO increase, suggesting the body’s response is not as straightforward as “more EPO equals more hemoglobin.” A study tracking male adolescent athletes over three years found that total hemoglobin mass per lean body weight did not differ between athletes and non-athletes, and both groups gained hemoglobin at the same rate during growth, although athletes did have higher plasma volumes. Exercise training, in other words, may boost fitness without necessarily raising hemoglobin concentration.

Testosterone and Hormonal Influences

Testosterone is one of the most potent non-pathological drivers of hemoglobin. Men naturally have higher hemoglobin than women in large part because of higher testosterone levels, and exogenous testosterone therapy reliably raises hemoglobin further. In a study of men receiving testosterone, hemoglobin increased by roughly 7% to 10%, driven by a rise in EPO and a simultaneous drop in hepcidin and ferritin, meaning testosterone both stimulated new red blood cell production and unlocked iron from storage to fuel it.

This dual mechanism makes testosterone especially effective at raising hemoglobin, but it also makes polycythemia (hemoglobin that is too high) one of the most common side effects of testosterone replacement therapy. Men on testosterone need regular blood work to check for this, and dose adjustments or blood donation are standard ways to manage it.

When Hemoglobin Rises for the Wrong Reasons

Not every increase in hemoglobin is welcome. Several medical conditions drive hemoglobin above normal range, and understanding these matters because the causes and risks are quite different from the nutritional picture.

Chronic lung diseases like COPD impair gas exchange, leading to chronic low oxygen levels. The body responds the way it would at altitude, cranking up red blood cell production. In a study of COPD patients, severe resting low oxygen was associated with about a 3.5-fold higher odds of polycythemia, and current smoking roughly doubled the risk on top of that. Heavy smoking on its own can cause secondary polycythemia by damaging pulmonary gas exchange, and the elevated hemoglobin, red cell count, and hematocrit seen in heavy smokers reflect a body struggling to compensate for carbon monoxide exposure and impaired lungs.

Obstructive sleep apnea is another surprisingly common driver. Repeated airway collapse during sleep causes intermittent drops in blood oxygen, and the body may respond with increased red blood cell production. A meta-analysis found that sleep apnea is associated with elevated hemoglobin and hematocrit. The association is strongest in men with severe sleep apnea, and average overnight oxygen saturation is a better predictor of polycythemia than the frequency of breathing pauses alone.

Then there is polycythemia vera, a bone marrow disorder where a mutation in the JAK2 gene causes red blood cells to multiply out of control regardless of oxygen levels. Over 95% of patients with this condition carry the specific V617F mutation, and the resulting overproduction of red blood cells raises both hemoglobin and the risk of blood clots.

Dehydration and Other False Elevations

A hemoglobin reading on a blood test reflects concentration: grams of hemoglobin per volume of blood. Anything that shrinks the fluid portion of blood will make hemoglobin appear higher without a single extra red blood cell being produced. Dehydration is the most common culprit. In a study of young men cycling in hot conditions, hemoglobin values were significantly higher when they received no fluids compared to when they drank water or an isotonic beverage. Researchers studying mountaineers in the Himalayas confirmed that the initial spike in hemoglobin seen at altitude is largely a hemoconcentration effect from fluid loss rather than new red blood cell production.

This matters practically. If you are tracking hemoglobin and see a jump after an intense workout, a bout of illness with vomiting, or a blood draw taken first thing in the morning after overnight fasting, consider whether dehydration might be inflating the number. Rehydrating and retesting usually reveals your true baseline.

Erythropoietin-Stimulating Agents

For people whose kidneys no longer produce enough EPO, such as those with advanced chronic kidney disease, synthetic versions of the hormone can restore hemoglobin to functional levels. Recombinant human erythropoietin (epoetin alfa) was approved by the FDA in 1989 and has become the standard treatment for the EPO-deficient anemia that accompanies most cases of kidney disease. These drugs are also used in certain cancer-related anemias, though with tighter restrictions because of safety concerns when hemoglobin is pushed too high.

Why Hemoglobin Norms Vary and What Counts as “Too High”

Reference ranges for hemoglobin differ by sex, age, ethnicity, and geography. Typical adult ranges are roughly 13.5 to 17.5 g/dL for men and 12.0 to 15.5 g/dL for women, but these shift with age. A large dataset from northern Italy showed that a substantial share of people over 75 fall below the lower cutoff: about 40% of men and 28% of women, even after removing those with known diseases like diabetes or kidney problems. Whether this represents a genuine age-related decline or undiagnosed conditions is still debated, but it means that older adults often have lower starting points when trying to raise hemoglobin.

On the other end, hemoglobin that climbs too high thickens the blood and impairs flow. This hyperviscosity raises the risk of stroke, heart attack, deep vein thrombosis, and pulmonary embolism. The danger is most acute in conditions that cause sustained overproduction, like polycythemia vera or chronic cyanotic heart disease, where the combination of excess red cells and sluggish circulation can be life-threatening. Even in people using testosterone therapy or EPO-stimulating drugs for legitimate medical reasons, overshooting the hemoglobin target is something clinicians actively guard against. Raising hemoglobin is useful up to a point, but the goal is always to land within a healthy range rather than maximize the number.